Trexquant Investment LP - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 169 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.93 and the average weighting 0.2%.

Quarter-by-quarter ownership
Trexquant Investment LP ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$250,170
-42.0%
50,336
-42.3%
0.01%
-41.7%
Q1 2023$431,064
-38.7%
87,260
-22.0%
0.01%
-40.0%
Q4 2022$703,757
+316.4%
111,885
+653.3%
0.02%
+150.0%
Q2 2022$169,000
-73.3%
14,853
-38.9%
0.01%
-84.9%
Q2 2021$634,000
+49.9%
24,321
+117.0%
0.05%
+96.3%
Q3 2020$423,000
-35.3%
11,207
-26.7%
0.03%
-40.0%
Q2 2020$654,000
+22.5%
15,280
-44.4%
0.04%
+15.4%
Q1 2020$534,000
+46.3%
27,481
+95.5%
0.04%
+77.3%
Q4 2019$365,00014,0600.02%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$46,213,00013.24%
Wildcat Capital Management, LLC 1,716,370$44,111,0005.71%
TPG Group Holdings (SBS) Advisors, Inc. 18,716,306$481,009,0004.77%
Copernicus Capital Management, LLC 15,000$386,0004.67%
Coastal Bridge Advisors, LLC 301,240$7,742,0001.79%
Lombard Odier Asset Management (Switzerland) SA 914,416$23,500,0001.46%
Casdin Capital, LLC 2,100,000$53,970,0001.34%
Pier Capital, LLC 450,182$11,570,0001.20%
Ghost Tree Capital, LLC 150,000$3,855,0001.13%
Sessa Capital IM, L.P. 750,000$19,275,0000.95%
View complete list of ALLOGENE THERAPEUTICS INC shareholders